Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury

NCT: NCT05218447 · ACTIVE_NOT_RECRUITING

NCT IDNCT05218447
StatusACTIVE_NOT_RECRUITING
Start Date2022-05-20
Completion2026-09-14
SponsorBaylor Research Institute (OTHER)
First posted
Last updated

Brief Summary

The DOOR SCI project examines dosing effects of robotic gait training (RGT) and transcranial magnetic stimulation (TMS) initiated during inpatient rehabilitation and continued through early outpatient rehabilitation

Frequently Asked Questions

What is Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury?

Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury is a clinical trial registered under NCT05218447. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05218447?

The current status of NCT05218447 (Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury) is: ACTIVE_NOT_RECRUITING.

When did Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury start?

Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury started on 2022-05-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑